Tuberculosis and tuberculin skin test reactivity in pediatric patients with celiac disease

Nafiye Urganci1, Derya Kalyoncu2,3

  • 1Division of Pediatric Gastroenterology, Sisli Etfal Training and Research Hospital, Istanbul, Turkey.

Minerva Pediatrica
|January 20, 2017
PubMed

Insights

Pediatric celiac disease (CD) patients show similar tuberculin skin test (TST) reactivity to healthy children. However, CD patients with positive TST results have a higher incidence of tuberculosis and latent tuberculosis infection (LTBI).

Area of Science:

  • Pediatric immunology
  • Infectious diseases
  • Gastroenterology

Background:

  • Celiac disease (CD) is an autoimmune disorder affecting children.
  • Assessing immune response in pediatric CD patients is crucial.
  • Tuberculin skin test (TST) is a common method for evaluating tuberculosis exposure.

Purpose of the Study:

  • To evaluate tuberculin skin test (TST) reactivity in children with celiac disease (CD).
  • To identify factors associated with TST reactivity in pediatric CD patients.
  • To compare TST reactivity between CD patients and healthy controls.

Main Methods:

  • A cohort of 28 pediatric CD patients and 28 healthy controls underwent TST.
  • Demographic, clinical, and vaccination data were collected.
  • Association between TST results and factors like malnutrition and gluten-free diet compliance were analyzed.

Main Results:

  • No significant difference in TST reactivity (induration size) was found between CD patients and controls.
  • 32% of CD patients were anergic; malnutrition was noted in one-third of these.
  • A higher prevalence of tuberculosis disease and latent tuberculosis infection (LTBI) was observed in TST-positive CD patients compared to controls (P=0.0007).

Conclusions:

  • Children with celiac disease may have increased susceptibility to tuberculosis.
  • TST is a viable tool for identifying M. tuberculosis infection in BCG-vaccinated children with CD.
  • Further research with larger cohorts is warranted to confirm these findings.
Abstract

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
592
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.2K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.1K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
719
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.8K
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
80